Reproducibility of sputum differential cell counts is not affected by squamous epithelial cells

Journal of Asthma

Volumn 48, Issue 9, 2011, Pages 952-956

  Sohani, Zahra N ^a   Strinich, Tara X ^a   Watson, Brittany ^a   Smith, Steven G ^a   Torek, Abbey ^a   Howie, Karen J ^a   Gauvreau, Gail M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Asthma; Eosinophils; Intraclass correlation; Macrophages; Neutrophils; Reproducibility

Indexed keywords

ADULT; ARTICLE; ASTHMA; BLOOD CELL COUNT; CELL SUSPENSION; CLINICAL ARTICLE; DISEASE SEVERITY; EOSINOPHIL COUNT; FEMALE; HUMAN; LEUKOCYTE COUNT; MACROPHAGE; MALE; NEUTROPHIL COUNT; REPRODUCIBILITY; SPUTUM ANALYSIS; SPUTUM DIFFERENTIAL CELL COUNT; SQUAMOUS EPITHELIUM;

ADULT; ASTHMA; CELL COUNT; EPITHELIAL CELLS; FEMALE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SPUTUM; YOUNG ADULT;

EID: 80054965608     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2011.617477     Document Type: Article

References (24)

1. Pallan S, Mahony JB, OByrne PM, Nair P. Asthma management by monitoring sputum neutrophil count. Chest. 2008; 134:628-630
2. Hargreave FE. Quantitative sputum cell counts as a marker of airway inflammation in clinical practice. Curr Opin Allergy Clin Immunol 2007; 7:102-106
3. DSilva L, Gafni A, Thabane L, Jayaram L, Hassack P, Hargreave FE, Nair P. Cost analysis of monitoring asthma treatment using sputum cell counts. Can Respir J. 2008; 15:370-374
4. Malerba M, Ragnoli B, Radaeli A, Tantucci C. Usefulness of exhaled nitric oxide and sputum eosinophils in the long-term control of eosinophilic asthma. Chest. 2008; 134:733-739
5. Gauvreau GM, Watson RM, OByrne PM. Kinetics of allergeninduced airway eosinophilic cytokine production and airway inflammation. Am J Respir Crit Care Med 1999; 160:640-647
6. Gauvreau GM, Doctor J, Watson R, Jordana M, OByrne PM. Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation. Am J Respir Crit Care Med 1996; 154:1267-1271
7. Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, Hargreave FE, OByrne PM. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med. 2009; 360:985-993
8. Boot JD, Panzer P, Diamant Z. A critical apraisal of methods used in early clinical development of novel drugs for treatment of asthma. Pulm Pharmacol Ther 2007; 20:201-219
9. Efthimiadis A, Spanevello A, Hamid Q, Kelly MM, Linden M, Louis R, Pizzichini MMM, Pizzichini E, Ronchi C, Van Overveld F, Djukanovic R. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J 2002; 20(Suppl. 37):19s-23s
10. Kelly MM, Efthimiadis A, Hargreave FE. Induced sputum: selection method. In: Rogers DF, Donnelly LE, eds. Methods in Molecular Medicine. Human Airway Inflammation: Sampling Techniques and Analytical Protocols. London: Humana Press, 2001:77-91
11. Gershman NH, Wong HH, Liu JT, Mahlmeister MJ, Fahy JV. Comparison of two methods of collecting induced sputum in asthmatic subjects. Eur. Respir. J. 1996; 9:2448-2453
12. Ward R, Woltmann G, Wardlaw AJ, Pavord ID. Between-observer repeatability of sputum differential cell counts. Influence of cell viability and squamous cell contamination. Clin Exp Allergy 1998; 29:248-252
13. Simpson JL, Timmins NL, Fakes K, Talbot PI, Gibson PG. Effect of saliva contamination on induced sputum cell counts, IL-8 and eosinophil cationic protein levels. Eur Respir J 2004; 23:759-762
14. Hunter CJ, Brightling CE, Woltmann G, Wardlaw AJ, Pavord ID. A comparison of the validity of different diagnostic tests in adults with asthma. Chest. 2002; 121:1051-1057
15. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw AJ, Pavord ID. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet. 2002; 360:1715-1721
16. Green RH, Brightling CE,Woltmann G, Parker D,Wardlaw AJ, Pavord ID. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax. 2002; 57:875-879
17. Parameswaran K, Hargreave FE. The use of sputum cell counts to evaluate asthma medications. Br J Clin Pharmacol 2001; 52: 121-128
18. Pizzichini MM, Popov TA, Efthimiadis A, Hussack P, Evans S, Pizzichini E, Dolovich J, Hargreave FE. Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am J Respir Crit Care Med. 1996; 154:866-9
19. Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, Gleich GJ, Dolovich J, Hargreave FE. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154:308-17
20. Cockcroft DW, Airway responsiveness: measurement and interpretation. Mississauga (ON): Astra Pharmaceuticals Canada Ltd. c1985. Measure of airway responsiveness to inhaled histamine or methacholine; method of continuous aerosol generation and tidal breathing inhalation, 22-28
21. OByrne PM, Dolovich J, Hargreave FE. Late asthmatic responses. Am Rev Respir Dis 1987; 136:740-751
22. Cockcroft DW, Davis BE, Boulet LP, Deschesnes F, Gauvreau GM, OByrne PM, Watson RM. The links between allergen skin test sensitivity, airway responsiveness and airway response to allergen. Allergy. 2005; 60:56-59
23. Spanevello A, Migliori GB, Sharara A, Ballardini L, Bridge P, Pisati P, Neri M, Ind PW. Induced sputum to assess airway inflammation: a study of reproducibility. Clin Exp Allergy. 1997; 27:1138-1144
24. Belda J, Leigh R, Parameswaran K, OByrne PM, Sears MR, Hargreave FE. Induced sputum counts in healthy adults. Am J Respir Crit Care Med. 2000; 161:475-478